Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

~Uptick Halt... Winner Winner!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
VMB-1 Member Profile
 
Followed By 115
Posts 5,794
Boards Moderated 0
Alias Born 04/17/10
160x600 placeholder
Aravive EPS beats by $0.01, misses on revenue Seeking Alpha - 5/6/2021 7:26:21 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 7:15:18 AM
Aravive Reports First Quarter 2021 Financial Results and Announces Plans to Investigate AVB-500 in Clinical Trial as First-L... GlobeNewswire Inc. - 5/6/2021 7:00:00 AM
Aravive shares rise after dosing first patient in late-stage ovarian cancer study Seeking Alpha - 4/27/2021 10:54:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 7:11:36 AM
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant... GlobeNewswire Inc. - 4/27/2021 7:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/15/2021 7:45:28 AM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/24/2021 12:34:58 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/24/2021 12:33:36 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/23/2021 7:06:44 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/22/2021 7:13:50 PM
Clovis Oncology, Marker Therapeutics leads healthcare gainers; Idera Pharmaceuticals, Praxis Precision Medicines among major ... Seeking Alpha - 3/19/2021 11:04:17 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/17/2021 4:07:28 PM
Aravive shares rise on Q4 results, pipeline updates Seeking Alpha - 3/16/2021 10:18:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/16/2021 7:16:07 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2021 7:11:57 AM
Aravive EPS beats by $0.27, beats on revenue Seeking Alpha - 3/16/2021 7:06:56 AM
Aravive Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates GlobeNewswire Inc. - 3/16/2021 7:00:00 AM
Aravive to Present Phase 1b Data Evaluating AVB-500 in Platinum Resistant Ovarian Cancer at 2021 Society of Gynecologic Oncol... GlobeNewswire Inc. - 3/12/2021 7:00:00 AM
Aravive shares rise 8% as BTIG initiates with a buy Seeking Alpha - 3/8/2021 10:28:42 AM
Aravive starts dosing in Phase 1b/2 AVB-500 cancer study Seeking Alpha - 3/8/2021 8:06:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/8/2021 7:05:50 AM
Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcino... GlobeNewswire Inc. - 3/8/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2021 8:01:42 AM
Aravive to Participate in Upcoming Virtual Investor Conferences in March GlobeNewswire Inc. - 3/2/2021 7:00:00 AM
VMB-1   Wednesday, 11/20/19 09:47:31 AM
Re: VMB-1 post# 6
Post # of 51 
~Uptick Halt... Winner Winner!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences